<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000044981">
  <TermName>LY293111</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called leukotriene B4 receptor antagonists.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>LY293111</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Es un tipo de antagonista del receptor B4 de leucotrieno.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
</GlossaryTerm>
